Such phenomena indicate that it is not a biofilm-phenotype per se that drives lung disease in the setting of CF and other chronic pulmonary disease states, but the metabolic and functional disruption of pulmonary mucin that significantly contributes to disease progression. Here, MUC5AC is linked to lung disorder.